Open-Label Study of Dimethyl Fumarate in Adults With Type 1 Diabetes | MicrobiomeTrials← Back to trialsNCT07548996
Open-Label Study of Dimethyl Fumarate in Adults With Type 1 Diabetes
RecruitingPHASE2, PHASE3INTERVENTIONAL
Trial Details
Start: 2026-04-27Est. Completion: 2028-12-31
Enrollment target: 96 participants Locations- Jiangsu Provincial Hospital, Nanjing, Jiangsu, China
Other microbiome trials you might be interested in
Type 2 Diabetes Mellitus (T2DM), Obesity, Overweight
Type 2 Diabetes Mellitus (T2DM) is a progressive metabolic disease, often compounded by obesity, that leads to serious l…
Multiple LocationsEst. completion Jan 12, 2027
Non-alcoholic Fatty Liver Disease
The purpose of this study is to assess the safety and efficacy of efimosfermin alfa in the resolution of steatohepatitis…
Chandler, United StatesEst. completion Mar 29, 2028
A 12-month randomized, controlled, parallel-arm trial, divided into 2 consecutive periods: (1) 6-month weight loss perio…
Chicago, United StatesCompleted Feb 1, 2025